Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

384 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.
Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, Kalantzi M, Herbots L, Sinnaeve P, Dens J, Maertens J, Rademakers F, Dymarkowski S, Gheysens O, Van Cleemput J, Bormans G, Nuyts J, Belmans A, Mortelmans L, Boogaerts M, Van de Werf F. Janssens S, et al. Among authors: mortelmans l. Lancet. 2006 Jan 14;367(9505):113-21. doi: 10.1016/S0140-6736(05)67861-0. Lancet. 2006. PMID: 16413875 Clinical Trial.
Functional recovery of subepicardial myocardial tissue in transmural myocardial infarction after successful reperfusion: an important contribution to the improvement of regional and global left ventricular function.
Bogaert J, Maes A, Van de Werf F, Bosmans H, Herregods MC, Nuyts J, Desmet W, Mortelmans L, Marchal G, Rademakers FE. Bogaert J, et al. Among authors: mortelmans l. Circulation. 1999 Jan 5-12;99(1):36-43. doi: 10.1161/01.cir.99.1.36. Circulation. 1999. PMID: 9884377
Recombinant P-selectin glycoprotein ligand-immunoglobulin, a P-selectin antagonist, as an adjunct to thrombolysis in acute myocardial infarction. The P-Selectin Antagonist Limiting Myonecrosis (PSALM) trial.
Mertens P, Maes A, Nuyts J, Belmans A, Desmet W, Esplugas E, Charlier F, Figueras J, Sambuceti G, Schwaiger M, Mortelmans L, Van de Werf F; PSALM investigators. Mertens P, et al. Among authors: mortelmans l. Am Heart J. 2006 Jul;152(1):125.e1-8. doi: 10.1016/j.ahj.2006.04.020. Am Heart J. 2006. PMID: 16824841 Clinical Trial.
Tomographic and planar quantitation of perfusion defects on technetium 99m-labeled sestamibi scans: evaluation in patients treated with thrombolytic therapy for acute myocardial infarction.
Mortelmans LA, Wackers FJ, Nuyts JL, Scheys IA, Brzostek T, Schiepers CW, Lesaffre EE, Suetens PL, Verbruggen AM, Van de Werf FJ. Mortelmans LA, et al. J Nucl Cardiol. 1995 Mar-Apr;2(2 Pt 1):133-43. doi: 10.1016/s1071-3581(95)80024-7. J Nucl Cardiol. 1995. PMID: 9420778
Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy.
Van de Werf F, Janssens L, Brzostek T, Mortelmans L, Wackers FJ, Willems GM, Heidbüchel H, Lesaffre E, Scheys I, Collen D, et al. Van de Werf F, et al. Among authors: mortelmans l. J Am Coll Cardiol. 1993 Aug;22(2):407-16. doi: 10.1016/0735-1097(93)90044-2. J Am Coll Cardiol. 1993. PMID: 8335810 Free article. Clinical Trial.
384 results